InMed Pharmaceuticals Statistics
Total Valuation
INM has a market cap or net worth of $9.24 million. The enterprise value is $7.00 million.
| Market Cap | 9.24M |
| Enterprise Value | 7.00M |
Important Dates
The last earnings date was Wednesday, September 9, 2026, after market close.
| Earnings Date | Sep 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INM has 6.64 million shares outstanding. The number of shares has increased by 447.08% in one year.
| Current Share Class | 5.49M |
| Shares Outstanding | 6.64M |
| Shares Change (YoY) | +447.08% |
| Shares Change (QoQ) | +31.90% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 35.93% |
| Float | 3.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.90 |
| P/TBV Ratio | 8.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37
| Current Ratio | 1.37 |
| Quick Ratio | 1.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -924.78 |
Financial Efficiency
Return on equity (ROE) is -156.77% and return on invested capital (ROIC) is -81.10%.
| Return on Equity (ROE) | -156.77% |
| Return on Assets (ROA) | -66.46% |
| Return on Invested Capital (ROIC) | -81.10% |
| Return on Capital Employed (ROCE) | -920.47% |
| Weighted Average Cost of Capital (WACC) | 9.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.09M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.30% in the last 52 weeks. The beta is 0.98, so INM's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -39.30% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 50.99 |
| Average Volume (20 Days) | 69,340 |
Short Selling Information
The latest short interest is 30,769, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 30,769 |
| Short Previous Month | 72,430 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.90M |
| Pretax Income | -11.37M |
| Net Income | -12.56M |
| EBITDA | -9.69M |
| EBIT | -9.90M |
| Earnings Per Share (EPS) | -$2.35 |
Balance Sheet
The company has $2.23 million in cash and no debt, with a net cash position of $2.23 million or $0.34 per share.
| Cash & Cash Equivalents | 2.23M |
| Total Debt | n/a |
| Net Cash | 2.23M |
| Net Cash Per Share | $0.34 |
| Equity (Book Value) | 1.08M |
| Book Value Per Share | 0.20 |
| Working Capital | 721,646 |
Cash Flow
| Operating Cash Flow | -8.64M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 205,271 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.64M |
| FCF Per Share | -$1.30 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -447.08% |
| Shareholder Yield | -447.08% |
| Earnings Yield | -136.01% |
| FCF Yield | -93.59% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |